A Sensitive, Portable Microfluidic Device for SARS-CoV-2 Detection from Self-Collected Saliva

Area of Science:

• Medical Diagnostics
• Biotechnology
• Infectious Disease Research

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, necessitates rapid and accessible diagnostic methods.
• Traditional SARS-CoV-2 detection involves complex RNA isolation and real-time quantitative PCR (RT-qPCR).
• Direct detection methods from saliva bypass RNA isolation, offering faster results.

Purpose of the Study:

• To develop a portable, integrated system for direct SARS-CoV-2 nucleic acid detection from saliva.
• To create a point-of-care device for accessible and timely COVID-19 diagnosis.
• To automate the detection process from sample input to result output.

Main Methods:

• Development of a microfluidic cartridge for saliva processing.
• Integration of heating, primer mixing, and multiplex real-time quantitative PCR.
• Direct detection of SARS-CoV-2 genomic material without prior RNA isolation.

Main Results:

• The system successfully detects SARS-CoV-2 nucleic acids directly from saliva.
• Achieved a detection sensitivity of 1000 copies/mL for SARS-CoV-2 RNA or virus.
• Demonstrated consistency and automation in the sample-to-result process.

Conclusions:

• The portable microfluidic system provides a rapid and automated method for SARS-CoV-2 detection.
• Direct saliva analysis enhances accessibility for point-of-care COVID-19 testing.
• This technology offers a promising solution for timely diagnosis and intervention during pandemics.